Introduction. Acute leukaemias in children constitute a heterogeneous group of malignant haematological disorders characterised by the uncontrolled proliferation of immature bone marrow cells. Their clinical and biological features vary according to leukaemia subtype and population context.
The objective of the study. The objective of the study was to analyse the demographic, clinical, haematological and biological characteristics of paediatric acute leukaemias diagnosed in the Paediatric Oncology Centre of El Hassi (Oran, Algeria), and to assess their associations with leukaemia subtypes.
Material and methods. This retrospective study included 163 children aged 2–15 years, who were newly diagnosed with acute leukaemia. Patients were classified as acute lymphoblastic leukaemia (B-ALL and T-ALL) or acute myeloblastic leukaemia (AML). Clinical and biological parameters were compared using appropriate statistical methods.
Results. Acute lymphoblastic leukaemia (ALL) accounted for most cases and predominantly affected children under 10 years of age, whereas AML occurred more frequently in older children. Clinical manifestations—including asthenia, thrombocytopenia, lymphadenopathy, splenomegaly and hepatomegaly—were more common in lymphoblastic forms. Biologically, ALL, particularly T-ALL, was characterised by marked hyperleukocytosis, high blast infiltration and elevated lactate dehydrogenase (LDH) levels, reflecting increased proliferative activity.
Conclusions. This study highlights that each acute leukaemia subtype is associated with a distinct clinical and biological profile. Early identification of these profiles at the time of diagnosis may improve patient stratification and contribute to more appropriate therapeutic management in children with acute leukaemia.
Keywords: hyperleukocytosis, bone marrow blasts, immunophenotyping, lactate dehydrogenase, thrombocytopenia.
The objective of the study. The objective of the study was to analyse the demographic, clinical, haematological and biological characteristics of paediatric acute leukaemias diagnosed in the Paediatric Oncology Centre of El Hassi (Oran, Algeria), and to assess their associations with leukaemia subtypes.
Material and methods. This retrospective study included 163 children aged 2–15 years, who were newly diagnosed with acute leukaemia. Patients were classified as acute lymphoblastic leukaemia (B-ALL and T-ALL) or acute myeloblastic leukaemia (AML). Clinical and biological parameters were compared using appropriate statistical methods.
Results. Acute lymphoblastic leukaemia (ALL) accounted for most cases and predominantly affected children under 10 years of age, whereas AML occurred more frequently in older children. Clinical manifestations—including asthenia, thrombocytopenia, lymphadenopathy, splenomegaly and hepatomegaly—were more common in lymphoblastic forms. Biologically, ALL, particularly T-ALL, was characterised by marked hyperleukocytosis, high blast infiltration and elevated lactate dehydrogenase (LDH) levels, reflecting increased proliferative activity.
Conclusions. This study highlights that each acute leukaemia subtype is associated with a distinct clinical and biological profile. Early identification of these profiles at the time of diagnosis may improve patient stratification and contribute to more appropriate therapeutic management in children with acute leukaemia.
Keywords: hyperleukocytosis, bone marrow blasts, immunophenotyping, lactate dehydrogenase, thrombocytopenia.
Address for correspondence: Meriem Rabia ZAHZEH AIT KACI
Department of Biology, Faculty of Natural and Life Sciences, Djillali Liabes University
Address: BP n°89, Sidi Bel Abbes 22000, Algeria
E-mail address: rabia.zahzeh@univ-sba.dz
Phone: +213549878405
